We are preparing to review four stories on the new Swedish mammography study. We hope to post those reviews within a few days. Why does it take so long? Our reviewers do not work on this project fulltime and we will have three reviewers evaluate each story. That takes time. We hope you think it’s [...]
What started off as a longer piece in the The Daily Telegraph of the UK ended up being shortened as it traveled across the ocean. The Montreal Gazette, for example, gutted it in half, from more than 600 words down to fewer than 300 words, but leaving in extravagant claims like: • could allow scientists [...]
Dr. Otis Brawley has taken the gloves off on prostate cancer screening. Brawley, chief medical officer of the American Cancer Society, makes some powerful statements about controversies in prostate cancer screening in a new YouTube video that is billed as the first of a series that the Cancer Society will post on discussions with ACS [...]
On MSNBC, “Erectile dysfunction drug ads too hot for prime time?“ An AP story, “$93,000 cancer drug: How much is a life worth? “ Guy Boulton of the Milwaukee Journal-Sentinel on “Research could be key to lower health spending: Comparative-effectiveness studies can reduce spending on treatments that are ineffective or no more effective than less [...]
Another fine example of what local television news can do with complex health topics when serious reporters are given time to pursue stories in-depth. Jeff Baillon of KMSP-TV in Minneapolis-St. Paul (a former health journalism graduate student of mine) reported on the conflicting opinions breast cancer patients are given about followup testing. It’s an important [...]
Last week journalists got an email from the National Press Foundation (NPF) inviting them to apply for another all-expenses-paid program for which drug company Pfizer is contributing some of the funding. The topic this time is Alzheimer’s Disease – another field in which Pfizer makes products. Readers of this blog know that I have led [...]
One part of the health care law that took effect this week is widely reported as “establishing a menu of preventive procedures, such as colonoscopies, mammograms and cholesterol screening, that must be covered without co-payments.” For example, one of my local papers, the Star Tribune, wrote, “Some people will no longer have to pay for [...]
That’s the way Merrill Goozner analyzes the Avandia story – a terrific analysis focusing on the fact that “The Food and Drug Administration today slapped new restrictions on GlaxoSmithKline’s diabetes drug Avandia (rosiglitazone), while the European Union suspended its marketing entirely.” Read the entire column – a GoozNews gem.
On the eve of the FDA’s Avastin announcement last night (and with no apparent reference to that important contextual point – although I acknowledge I didn’t see the entire newscast), the NBC Nightly News last night attempted to report on the problem some patients encounter in the face of an awful economy and astronomical cancer [...]
Some past studies have not shown that care management lowers costs. But a study published in this week’s New England Journal of Medicine reports lower costs and fewer hospital admissions in people who received telephone-based care management that included the use of shared decision-making tools to help patients understand that they have options and to [...]